# Sino Biopharmaceutical acquires Softhale for US$110 million

Sino Biopharmaceutical Ltd, through its subsidiary invoX Pharma Ltd, acquired 100% of Softhale NV for US$110 million plus additional milestone payments. Softhale is a Belgian company developing respiratory disease treatments and a Soft Mist Inhalation device.

- Type: Acquisition
- Announced: 2021-03-30
- Where: Belgium
- Value: $110.0M
- Status: announced
- Products: Soft Mist Inhalation device, respiratory disease treatments
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Sino Biopharmaceutical](https://endata.com/companies/54111.md) (acquirer)
- [Softhale](https://endata.com/companies/54112.md) (target)

## Sources

- [softhale.com](https://www.softhale.com/news/press-release/invox-pharma-ltd-acquires-softhale/), 2021-03-30: "invoX Pharma Ltd, a wholly-owned subsidiary of the Company, entered into an agreement in relation to a 100% acquisition of SOFTHALE NV for US$110 million and additional payments related to regulatory and commercial milestones."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.